ArticleCancers2023

mAb14, a Monoclonal Antibody against Cell Surface PCNA: A Potential Tool for Sezary Syndrome Diagnosis and Targeted Immunotherapy.

Jamal Knaneh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.